Publications

A μ-opioid receptor superagonist analgesic with minimal adverse effects

 6
A μ-opioid receptor superagonist analgesic with minimal adverse effects

Tags:

Previous Article

Targeting stem cell marker LGR5 in colorectal cancer

Next Article

Pain-relieving drug with minimal addictive properties

Related Posts

Beneficial microbiome and diet interplay in early-onset colorectal cancer

Beneficial microbiome and diet interplay in early-onset...

 89

Chemotherapy-driven intestinal dysbiosis and indole-3-propionic acid rewire myelopoiesis to promote a metastasis- refractory state

Chemotherapy-driven intestinal dysbiosis and indole-3-p...

 28

Decoding immune aging at single-cell resolution

Decoding immune aging at single-cell resolution

 51